Why The FDA Can’t Be Flexible With 23andMe, By Law David Kroll, forbes.com “One of the challenges is the world has been evolving and yet we have legislation that reflects a different era.”– Margaret Hamburg, Commissioner, U.S. Food and Drug Administration Almost a year ago, at the inaugural Forbes… http://flip.it/690F3 Related articles Why The FDA … Continue reading FDA and 23andme: why they did it
You must be logged in to post a comment.